Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,553.68
(
-0.42%
)
US TECH 100
23,366.40
(
-0.65%
)
Dow Jones
46,146.34
(
-0.13%
)
Brent Oil
100.91
(
4.25%
)
Bitcoin
69,098.00
(
-2.54%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: drbio45 post# 37705

Saturday, 11/18/2006 4:31:12 PM

Saturday, November 18, 2006 4:31:12 PM

Post# of 257275
> MCU – Why doesn't mc-1 seem like an undervalued asset, in your opinion?<

It could be undervalued but, as with any drug with a novel MoA entering phase-3, the program has to be considered fairly high-risk.

Moreover, the company seems to be reticent about the IP protection for MC-1, which one would expect to be especially important for a drug that’s an analog of a vitamin.

p.s. This file contains some ppt slides on MCU and related subjects:
http://www.westlink.ca/annualconference/documents/DawsonReimer_000.pdf

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today